Using immune response modifiers for urogenital clamidiosis. Mathematic simulation and forecast of clamidiosis epidemiological process


Cite item

Abstract

There was an analysis of the role immune response modifiers (by the example of Cycloferon) play as a part of treatment schemes of urogenital clamidiosis from the point of view of public health. A math model of the chlamydia infection dynamics in a hypothetic cohort of women running a high risk of infection (commercial sex workers) and their clients was used for the analysis. The data of the study of commercial sex workers from ten regions of the Russian Federation as well as data published on the Cycloferon treatment efficacy were used for model calibration. The resulting data confirm that making immune response modifiers a part of the urogenital clamidiosis treatment regimen decreases the prevalence of the disease in the population by 6-30%. The strategy aimed at making the drug a part of the treatment regimen for the risk group patients seems to be most efficient.

References

  1. Инфекции, передаваемые половым путем (ИППП), и ВИЧ- инфекция в группах риска. Распространяются ли возбудители по одним и тем же сетям? / С. Плавинский, А. Баринова, К. Ерошина и др. // Российский семейный врач. 2009. Т. 13, № 1. С. 26-31.
  2. Инфекции, передающиеся половым путем, ВИЧ-инфекция и эффективность программ снижения вреда в Российской Федерации / С. Плавинский, К. Ерошина, А. Баринова и др. Москва: ОИЗ УКЦ, 2009. С. 48.
  3. Плавинский С. Моделирование ВИЧ-инфекции и других заразных заболеваний человека и оценка численности групп риска. Введение в математическую эпидемиологию. Москва: ОИЗ УКЦ, 2009. С. 100.
  4. Рыбалкин С.Б., Мирзабалаева А.К. Альтернативные подходы к терапии урогенитальных заболеваний с целью сохранения репродуктивного здоровья / Методические рекомендации и руководство для врачей-клиницистов. Санкт-Петербург, 2000. С. 37.
  5. Урогенитальный трихомониаз / Д.К. Ермоленко, В.А. Исаков, С.Б. Рыбалкин и др. Санкт-Петербург - Великий Новгород: Санкт-Петербургский НИИЭМ им. Пастера, 2007. С. 120.
  6. Chlamydial heat shock protein 60-specific T cells in inflamed salpingeal tissue / A. Kinnunen, P. Molander, R. Morrison et al. // Fertil. Steril. 2002. Jan. Vol. 77. P. 162-166.
  7. Chlamydial persistence: beyond the biphasic paradigm / R.J. Hogan, S.A. Mathews, S. Mukhopadhyay et al. // Infect. Immun. 2004. Apr. Vol. 72. P. 1843-1855.
  8. Kelly K.A. Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms // Int. Rev. Immunol. 2003. Vol. 22. P. 3-41.
  9. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results / L. Westrom, R. Joesoef, G. Reynolds et al. // Sex Transm Dis. 1992. Vol. 19. P. 185-192.
  10. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease / S.D. Hillis, L.M. Owens, P.A. Marchbanks et al. // Am. J. Obstet. Gynecol. 1997. Jan. Vol. 176. P. 103-107.
  11. Ward M.E. The immunobiology and immunopathology of chlamydial infections // APMIS. 1995. Nov. Vol. 103. P. 769-796.
  12. Wasserheit J.N., Aral S.O. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies // J. Infect. Dis. 1996. Oct. Vol. 174 Suppl 2. P. S201-213.

Copyright (c) 2010 BARINOVA A.N., PLAVINSKY S.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies